Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Immunotherapy Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Immunotherapy Drugs Market, by Type, 2018-2027 (USD Billion)
1.2.3. Immunotherapy Drugs Market, by Therapeutic Area, 2018-2027 (USD Billion)
1.2.4. Immunotherapy Drugs Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunotherapy Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunotherapy Drugs Market Dynamics
3.1. Immunotherapy Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Immunotherapy Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Immunotherapy Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Immunotherapy Drugs Market by Type, Performance - Potential Analysis
5.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Immunotherapy Drugs Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Checkpoint Inhibitors
5.4.3. Interferons & Interleukins
5.4.4. Other Immunotherapies
Chapter 6. Global Immunotherapy Drugs Market, by Therapeutic Area
6.1. Market Snapshot
6.2. Global Immunotherapy Drugs Market by Therapeutic Area, Performance - Potential Analysis
6.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Therapeutic Area 2017-2027 (USD Billion)
6.3.1. Cancer
6.3.2. Autoimmune & Inflammatory Diseases
6.3.3. Infectious Diseases
6.3.4. Others
Chapter 7. Global Immunotherapy Drugs Market, by End-User
7.1. Market Snapshot
7.2. Global Immunotherapy Drugs Market by End-User, Performance - Potential Analysis
7.3. Global Immunotherapy Drugs Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. Immunotherapy Drugs Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others
Chapter 8. Global Immunotherapy Drugs Market, Regional Analysis
8.1. Immunotherapy Drugs Market, Regional Market Snapshot
8.2. North America Immunotherapy Drugs Market
8.2.1.1. U.S. Immunotherapy Drugs Market
8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
8.2.1.3. Therapeutic Area breakdown estimates & forecasts, 2017-2027
8.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Immunotherapy Drugs Market
8.3. Europe Immunotherapy Drugs Market Snapshot
8.3.1. U.K. Immunotherapy Drugs Market
8.3.2. Germany Immunotherapy Drugs Market
8.3.3. France Immunotherapy Drugs Market
8.3.4. Spain Immunotherapy Drugs Market
8.3.5. Italy Immunotherapy Drugs Market
8.3.6. Rest of Europe Immunotherapy Drugs Market
8.4. Asia-Pacific Immunotherapy Drugs Market Snapshot
8.4.1. China Immunotherapy Drugs Market
8.4.2. India Immunotherapy Drugs Market
8.4.3. Japan Immunotherapy Drugs Market
8.4.4. Australia Immunotherapy Drugs Market
8.4.5. South Korea Immunotherapy Drugs Market
8.4.6. Rest of Asia Pacific Immunotherapy Drugs Market
8.5. Latin America Immunotherapy Drugs Market Snapshot
8.5.1. Brazil Immunotherapy Drugs Market
8.5.2. Mexico Immunotherapy Drugs Market
8.6. Rest of The World Immunotherapy Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Holding AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Pfizer Inc.
9.2.3. Merck & Co., Inc.
9.2.4. Novartis International AG
9.2.5. Johnson & Johnson
9.2.6. Sanofi S.A.
9.2.7. GlaxoSmithKline plc
9.2.8. AbbVie Inc.
9.2.9. Amgen Inc.
9.2.10. C.H. Boehringer Sohn AG & Co.. KG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



List of Figures


FIG 1. Global Immunotherapy Drugs market, research methodology
FIG 2. Global Immunotherapy Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Immunotherapy Drugs market, key trends 2019
FIG 5. Global Immunotherapy Drugs market, growth prospects 2020-2027
FIG 6. Global Immunotherapy Drugs market, porters 5 force model
FIG 7. Global Immunotherapy Drugs market, pest analysis
FIG 8. Global Immunotherapy Drugs market, value chain analysis
FIG 9. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 18. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 19. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 20. Global Immunotherapy Drugs market, regional snapshot 2017 & 2027
FIG 21. North America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 22. Europe Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 23. Asia Pacific Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 24. Latin America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 25. Global Immunotherapy Drugs market, company market share analysis (2019)


List of Tables


TABLE 1. Global Immunotherapy Drugs market, report scope
TABLE 2. Global Immunotherapy Drugs market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Immunotherapy Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Immunotherapy Drugs market estimates & forecasts by Therapeutic Area 2017-2027 (USD Billion)
TABLE 5. Global Immunotherapy Drugs market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 6. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 24. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 27. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. U.S. Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Canada Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 33. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. UK Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Germany Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. France Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 45. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. Spain Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Italy Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. ROE Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 57. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. China Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. India Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Japan Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 69. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. Australia Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. South Korea Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 77. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 78. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 79. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 80. ROPAC Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 81. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 82. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 83. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 84. Brazil Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 85. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 86. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 87. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 88. Mexico Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 89. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 90. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 91. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 92. ROLA Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 93. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 94. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 95. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 96. ROW Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 97. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 98. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 99. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 100. List of secondary sources, used in the study of global Immunotherapy Drugs market
TABLE 101. List of primary sources, used in the study of global Immunotherapy Drugs market
TABLE 102. Years considered for the study
TABLE 103. Exchange rates considered